Rapid Screening of Invasive Fungal Infections in the Hospital Setting Using the (1,3)-β-D-glucan Assay

被引：0

作者：

Hornberger, Maria M. ^{[1
]}

Patterson, Andrew T. ^{[2
]}

Kerford, Jane H. ^{[2
]}

Lenz, Brittany L. ^{[2
]}

Mir, Adnan ^{[3
,4
,5
]}

Dominguez, Arturo R. ^{[6
,7
]}

机构：

[1] San Antonio Uniformed Serv Hlth Educ Consortium, Transit Internship Program, Ft Sam Houston, TX USA

[2] San Antonio Uniformed Serv Hlth Educ Consortium, Dept Dermatol, Ft Sam Houston, TX USA

[3] Dermpath Diagnost, Port Chester, NY USA

[4] Weill Cornell Med, Dept Dermatol, New York, NY USA

[5] New York Med Coll, Dept Dermatol, New York, NY USA

[6] Univ Texas Southwestern, Dept Dermatol, Dallas, TX USA

[7] Univ Texas Southwestern, Dept Med, Dallas, TX USA

来源：

CUTIS | 2020年 / 106卷 / 01期

关键词：

PATIENT;

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Disseminated candidiasis and other invasive fungal infections are a substantial cause of morbidity and mortality in immunocompromised and critically ill patients. Diagnosis of disseminated candidiasis via blood culture and skin biopsy can be unreliable and may delay treatment. (1,3)-beta-D-glucan (BDG) assay is a rapid, cost-effective, noninvasive diagnostic screening tool for the dermatology hospitalist to consider.

引用

页码：33 / 36

页数：3

共 50 条

[21] β-D-Glucan Testing Is Important for Diagnosis of Invasive Fungal Infections
Theel, Elitza S.
Doern, Christopher D.
JOURNAL OF CLINICAL MICROBIOLOGY, 2013, 51 (11) : 3478 - 3483
[22] Detecting Invasive Fungal Disease in Surgical Patients: Utility of the (1→3)- β-D-Glucan Assay
Skubic, Jeffrey
Taghavi, Sharven
Castillo-Angeles, Manuel
Ramsis, Ramsis
Salim, Ali
Askari, Reza
SURGICAL INFECTIONS, 2020, 21 (05) : 461 - 464
[23] Invasive fungal infections and (1,3)-β-D-glucan serum concentrations in long-term intensive care patients
Presterl, Elisabeth
Parschalk, Bernhard
Bauer, Edith
Lassnigg, Andrea
Hajdu, Stefan
Graninger, Wolfgang
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2009, 13 (06) : 707 - 712
[24] Quantitative Characterization of the Amount and Length of (1,3)-β-D-glucan for Functional and Mechanistic Analysis of Fungal (1,3)-β-D-glucan Synthase
Chhetri, Abhishek
Loksztejn, Anna
Yokoyama, Kenichi
BIO-PROTOCOL, 2021, 11 (08):
[25] ASSESSMENT OF β-D-(1→3)-GLUCAN ASSAY FOR DIAGNOSIS OF INVASIVE FUNGAL INFECTIONS
Atalay, Altay
Sav, Hafize
Koc, Ayse Nedret
Yildiz, Orhan
Demir, Gonca
Eser, Bulent
Zararsiz, Gokmen
ACTA MEDICA MEDITERRANEA, 2014, 30 (03): : 685 - 690
[26] Detection of (1,3)-β-D-Glucan for the Diagnosis of Invasive Fungal Infection in Liver Transplant Recipients
Levesque, Eric
Rizk, Fadi
Noorah, Zaid
Ait-Ammar, Nawel
Cordonnier-Jourdin, Catherine
El Anbassi, Sarra
Bonnal, Christine
Azoulay, Daniel
Merle, Jean-Claude
Botterel, Francoise
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (04):
[27] Use of 1,3-β-D-glucan in invasive fungal diseases in hematology patients
Giacobbe, Daniele Roberto
Del Bono, Valerio
Viscoli, Claudio
Mikulska, Malgorzata
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2017, 15 (12) : 1101 - 1112
[28] 1,3-β-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia
Senn, Laurence
Robinson, James Owen
Schmidt, Sabine
Knaup, Marlies
Asahi, Nobuo
Satomura, Shinji
Matsuura, Shuuji
Duvoisin, Bertrand
Bille, Jacques
Calandra, Thierry
Marchetti, Oscar
CLINICAL INFECTIOUS DISEASES, 2008, 46 (06) : 878 - 885
[29] (1→3)-β-D-glucan testing for the detection of invasive fungal infections in immunocompromised or critically ill people
White, Sandra K.
Schmidt, Robert L.
Walker, Brandon S.
Hanson, Kimberly E.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (07):
[30] Multicenter clinical evaluation of the (1→3) β-D-glucan assay as an aid to diagnosis of fungal infections in humans
Ostrosky-Zeichner, L
Alexander, BD
Kett, DH
Vazquez, J
Pappas, PG
Saeki, F
Ketchum, PA
Wingard, J
Schiff, R
Tamura, H
Finkelman, MA
Rex, JH
CLINICAL INFECTIOUS DISEASES, 2005, 41 (05) : 654 - 659

← 1 2 3 4 5 →